Sofia, Bulgaria, November 24, 2023 – In accordance with the requirements of art. 115c, para. 4 of LPOS “Sopharma” AD notifies all shareholders of the Company about the decision of the EGM of “Sopharma” AD that took place on November 24, 2023 regarding the amount and type of dividend distributed and the terms and conditions for its distribution:

The EGM approves the proposal by the Board of Directors for the distribution of 6-month gross dividend amounting to BGN 0.90 (ninety stotinki) per share.

Sofia, Bulgaria, November 20, 2023 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that for the month of October 2023, the Company realized an increase in sales of 45% compared to the same month of the previous year, incl. 53% increase in domestic sales and 42% increase in export sales.

For the ten months from the beginning of 2023, sales increased by a total of 18%, incl. a 5% increase in domestic sales and a 27% increase in export sales.

Sofia, Bulgaria, 7 November, 2023 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that the Serbian Commission for Protection of Competition has authorized Sopharma AD to acquire the manufacturer Pharmanova in stages. The deal will take place in several stages, starting with the acquisition of 25% of the company's capital.